8-K
Current Report
Adaptimmune Therapeutics PLC Filed Acc 0001558370-22-015279
Agreement ended
- Item 1.02 Termination of a material definitive agreement
From the SEC's structured data for this filing
Loading adap-20221024x8k.htm…